JP2022518931A5 - - Google Patents

Info

Publication number
JP2022518931A5
JP2022518931A5 JP2021544194A JP2021544194A JP2022518931A5 JP 2022518931 A5 JP2022518931 A5 JP 2022518931A5 JP 2021544194 A JP2021544194 A JP 2021544194A JP 2021544194 A JP2021544194 A JP 2021544194A JP 2022518931 A5 JP2022518931 A5 JP 2022518931A5
Authority
JP
Japan
Prior art keywords
composition according
aav
vector
approximately
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021544194A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022518931A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/016235 external-priority patent/WO2020160486A1/en
Publication of JP2022518931A publication Critical patent/JP2022518931A/ja
Publication of JP2022518931A5 publication Critical patent/JP2022518931A5/ja
Priority to JP2025030051A priority Critical patent/JP2025098018A/ja
Pending legal-status Critical Current

Links

JP2021544194A 2019-02-01 2020-01-31 遅発型小児性神経セロイドリポフスチン沈着症2型に対するaavベクター治療法 Pending JP2022518931A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025030051A JP2025098018A (ja) 2019-02-01 2025-02-27 遅発型小児性神経セロイドリポフスチン沈着症2型に対するaavベクター治療法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962800131P 2019-02-01 2019-02-01
US62/800,131 2019-02-01
PCT/US2020/016235 WO2020160486A1 (en) 2019-02-01 2020-01-31 Aav vector treatment methods for late infantile neuronal ceroid lipofuscinosis type 2

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025030051A Division JP2025098018A (ja) 2019-02-01 2025-02-27 遅発型小児性神経セロイドリポフスチン沈着症2型に対するaavベクター治療法

Publications (2)

Publication Number Publication Date
JP2022518931A JP2022518931A (ja) 2022-03-17
JP2022518931A5 true JP2022518931A5 (https=) 2023-05-23

Family

ID=71841678

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021544194A Pending JP2022518931A (ja) 2019-02-01 2020-01-31 遅発型小児性神経セロイドリポフスチン沈着症2型に対するaavベクター治療法
JP2025030051A Withdrawn JP2025098018A (ja) 2019-02-01 2025-02-27 遅発型小児性神経セロイドリポフスチン沈着症2型に対するaavベクター治療法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025030051A Withdrawn JP2025098018A (ja) 2019-02-01 2025-02-27 遅発型小児性神経セロイドリポフスチン沈着症2型に対するaavベクター治療法

Country Status (9)

Country Link
US (1) US20220184188A1 (https=)
EP (1) EP3917522A4 (https=)
JP (2) JP2022518931A (https=)
CN (1) CN113891712A (https=)
AU (1) AU2020215592A1 (https=)
BR (1) BR112021015050A2 (https=)
CA (1) CA3127889A1 (https=)
MX (1) MX2021009250A (https=)
WO (1) WO2020160486A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3132379A1 (en) * 2019-03-22 2020-10-01 Rush University Medical Center Combination of nasal gene delivery and oral cinnamic acid, oleamide or gemfibrozil for lysosomal storage disorders
AU2022337146A1 (en) 2021-09-03 2024-03-14 Tacit Therapeutics, Inc. Rna editing via recruitment of spliceosome components
WO2025231406A1 (en) * 2024-05-02 2025-11-06 The Children's Hospital Of Philadelphia Methods to increase transduction of ependyma cells in brain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2132309A4 (en) * 2007-02-23 2011-01-05 Univ Florida COMPOSITIONS AND METHODS OF TREATING GLYCOLOGICAL MEMORY DISEASES
WO2012135857A1 (en) * 2011-03-31 2012-10-04 University Of Iowa Research Foundation Methods and compositions for treating brain diseases
US20140271550A1 (en) * 2013-03-14 2014-09-18 The Trustees Of The University Of Pennsylvania Constructs and Methods for Delivering Molecules via Viral Vectors with Blunted Innate Immune Responses
EP3024497B1 (en) * 2013-07-26 2021-01-13 University of Iowa Research Foundation Methods and compositions for treating brain diseases
US10900053B2 (en) * 2014-11-21 2021-01-26 University Of Florida Research Foundation, Incorporated Genome-modified recombinant adeno-associated virus vectors
KR102738860B1 (ko) * 2015-10-23 2024-12-04 유니버시티 오브 아이오와 리써치 파운데이션 리소좀 축적 질환 (lsd)을 갖는 포유동물의 치료 방법에 사용하기 위한 aav 입자를 포함하는 약제학적 조성물
CA3041548A1 (en) * 2016-11-04 2018-05-11 The Children's Hospital Of Philadelphia Gene transfer compositions, methods and uses for treating neurodegenerative diseases

Similar Documents

Publication Publication Date Title
JP2024009857A5 (https=)
JP2021106619A5 (https=)
JP2021087431A5 (https=)
JP2021118724A5 (https=)
JP2022549380A5 (https=)
JP2021019591A5 (https=)
JP2022504740A5 (https=)
JP2022068181A5 (https=)
JP2021523718A5 (https=)
JP2025078652A5 (https=)
JP2022508182A5 (https=)
JP2022518931A5 (https=)
JP2021003120A5 (https=)
RU2021102893A (ru) Модифицированные гены атаксии фридрейха и векторы для генной терапии
JP2020527333A5 (https=)
IL299325B1 (en) Variants of acid alpha-glucosidase and their uses
JP2022551744A5 (https=)
JP2023514242A5 (https=)
JP2021533805A5 (https=)
JP2022553307A5 (https=)
JP2024543918A5 (https=)
JP2023537980A5 (https=)
JP2023524024A5 (https=)
JP2024504611A5 (https=)
JP2024506266A5 (https=)